<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01007227</url>
  </required_header>
  <id_info>
    <org_study_id>743EndothelialMetsyd</org_study_id>
    <nct_id>NCT01007227</nct_id>
  </id_info>
  <brief_title>Metabolic Syndrome and Fingertip Endothelial Dysfunction</brief_title>
  <official_title>Achievement of Dietetic and Exercise Therapy Evaluated by Self-assessment Score Significantly Improved Endothelial Dysfunction in Patients With Metabolic Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kumamoto University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kumamoto University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Life-style intervention with dietetic and exercise therapy is an important fundamental
      approach to patients with metabolic syndrome (MetSyd) which may cause endothelial dysfunction
      leading to cardiovascular events. We investigated whether the life-style modification by
      dietetic and exercise instruction could improve endothelial dysfunction assessed by a new
      non-invasive and automatic device; digital reactive hyperemia peripheral arterial tonometry
      (RH-PAT).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Outline of methods RH-PAT was measured in high-risk patients under 70 years old. The MetSyd
      was defined according to guidelines of the National Cholesterol Education Program Third Adult
      Treatment Panel (NCEP - ATP III). We instructed all MetSyd patients about the dietetic and
      exercise therapy according to the Japan Atherosclerosis Society Guidelines for Prevention of
      Atherosclerotic Cardiovascular Diseases. we conducted a questionnaire survey of the
      self-assessment for dietetic and exercise instruction program, respectively.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial function assessed by RH-PAT</measure>
    <time_frame>About 1 year later</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Metabolic status including waist circumference</measure>
    <time_frame>About 1 year later</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Lifestyle instruction</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lifestyle instruction</intervention_name>
    <description>Instruction dietetic and exercise therapy</description>
    <arm_group_label>Lifestyle instruction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Under 70 years old and preserved left ventricular systolic function (left ventricular
             ejection fraction â‰¥ 50%)

        Exclusion Criteria:

          -  Severe valvular heart disease

          -  Atrial septal defect

          -  Myocarditis

          -  Cardiomyopathy

          -  Active inflammatory diseases

          -  Pulmonary hypertension

          -  Chronic kidney disease on hemodialysis

          -  Advanced hepatic disease

          -  Leukemia

          -  Schizophrenia; AND

          -  Cerebrovascular disease and residual hemiplegia.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kumamoto University Hospital</name>
      <address>
        <city>Kumamoto</city>
        <zip>860-8556</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 2, 2009</study_first_submitted>
  <study_first_submitted_qc>November 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 3, 2009</study_first_posted>
  <last_update_submitted>September 25, 2013</last_update_submitted>
  <last_update_submitted_qc>September 25, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kumamoto University</investigator_affiliation>
    <investigator_full_name>Seigo Sugiyama</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

